Recruiting

Vascular Disease

Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Code:

NCT03538639

Conditions

Vascular Dysfunction

Genetic Mutations

Genetic Predisposition

Eligibility Criteria

Sex: All

Age: 2 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

Background:

Some genetic diseases put increase the risk of heart and blood diseases, which are the number one cause of death and disability in the U.S. Researchers want to study diseases of the heart and/or blood vessels. They want to collect data and specimens from affected people, their family members, and healthy people.

Objective:

To study diseases of the heart and/or blood vessels.

Eligibility:

People age 2 and older who may have genetic disease affecting the heart and/or blood vessels Their relatives

Healthy volunteers

Design:

Participants will be screened with a medical history, physical exams, and imaging tests. Participants may have a few visits or visits for 2 weeks or more. This will depend on their age and disease status. Visits may include:

Photographs of the face and body

Heart tests

Samples taken of blood, urine, saliva, skin, and/or tissue

Scans. For some, a dye may be injected into a vein.

A six-minute walk test

Lung tests. For some, participants will blow into a tube. For others, they will breathe in a gas from a mask, have a small injection, then have a scan.

Stress tests while walking on a treadmill or riding a stationary bike

Ultrasound of veins and arteries

Devices outside the body testing the stiffness and function of arteries

Eye exam and eye tests. For some, a dye may be injected in a vein.

Blood pressure tests

Measurements of blood flow under the skin and in the arms and fingernail blood vessels

Devices outside the body testing flexibility of the blood vessels and skin, and skin temperature

Conditions

Vascular Dysfunction

Genetic Mutations

Genetic Predisposition

Study ID

NCT03538639

Start date

Jul 30, 2018

Status verified date

Aug 19, 2026

Completion date

May 15, 2037

Anticipated

Primary completion date

Nov 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 2 - 70+

Healthy Volunteers: Accepted

  • INCLUSION CRITERIA:
  • All subjects must be between the ages of 2-100 years old.
  • Affected pregnant women if they have been referred with a known or suspected pathology or if they become pregnant while on study.
  • Unaffected related pregnant women (including spouses/partners) for cord blood and tissue collection (surgical waste) only at the time of delivery.

EXCLUSION CRITERIA:

  • Healthy volunteers unable to give informed consent
  • Healthy volunteers who decline to have blood drawn and/or tissue studies or who do not consent to have samples stored for future research.
  • Cognitively impaired individuals who are not affected.
  • Cognitively impaired individuals not related to affected subjects.
  • Unaffected unrelated pregnant women.

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Arms

1

Adult index cases (affected) and relatives (affected and unaffected)

2

Child index cases (affected) and child relatives (affected and unaffected)

3

Healthy adult volunteers

Primary outcome measure

  • Rapid initiation of new, disease-specific investigations to enable the collection of data and biospecimens on affected subjects, their family members and healthy controls, and to assist in the generation of diagnoses and further the understandin... [ Time Frame: ongoing ]

Central Contacts and Locations

Central contacts

Locations

National Institutes of Health Clinical Center

Recruiting

Bethesda, Maryland, United States, 20892

Contacts

NIH Clinical Center Office of Patient Recruitment (OPR)

800-411-1222ccopr@nih.gov

More Information

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Last update posted

Aug 21, 2026

Last verified

Aug 19, 2026

Keywords

  • Etiology of Rare and Orphan Diseases with Vascular Phenotype
  • Natural History of Rare and Orphan Diseases with Vascular Phenotype
  • Pathophysiology of Uncommon Vascular Diseases
  • Undiagnosed Diseases
  • Rare Human Diseases with Vascular Features
  • Natural History

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Heart, Lung, and Blood Institute (NHLBI) on 2026-08-21.